

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | low-density lipoprotein particle clearance (GO:0034383) | 6.48269760 |
| 2 | fatty acid transmembrane transport (GO:1902001) | 5.17612258 |
| 3 | valine metabolic process (GO:0006573) | 5.17413382 |
| 4 | regulation of sequestering of triglyceride (GO:0010889) | 5.15087076 |
| 5 | triglyceride catabolic process (GO:0019433) | 4.91953554 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 4.80963071 |
| 7 | neutrophil activation involved in immune response (GO:0002283) | 4.79550056 |
| 8 | response to peptidoglycan (GO:0032494) | 4.78380674 |
| 9 | carnitine shuttle (GO:0006853) | 4.66361123 |
| 10 | acylglycerol catabolic process (GO:0046464) | 4.62990473 |
| 11 | neutral lipid catabolic process (GO:0046461) | 4.62990473 |
| 12 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 4.51082324 |
| 13 | plasma lipoprotein particle clearance (GO:0034381) | 4.41674500 |
| 14 | positive regulation of fatty acid oxidation (GO:0046321) | 4.31295429 |
| 15 | biotin metabolic process (GO:0006768) | 4.29520028 |
| 16 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.14237941 |
| 17 | glycosphingolipid catabolic process (GO:0046479) | 4.13796702 |
| 18 | regulation of mast cell degranulation (GO:0043304) | 4.13671119 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 4.09369785 |
| 20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.08697597 |
| 21 | negative regulation of interleukin-12 production (GO:0032695) | 4.08649038 |
| 22 | amino sugar catabolic process (GO:0046348) | 4.08529533 |
| 23 | complement activation, alternative pathway (GO:0006957) | 4.08511902 |
| 24 | regulation of cholesterol storage (GO:0010885) | 4.08390655 |
| 25 | brown fat cell differentiation (GO:0050873) | 4.07027674 |
| 26 | fatty acid homeostasis (GO:0055089) | 4.06855856 |
| 27 | fatty acid beta-oxidation (GO:0006635) | 4.04916339 |
| 28 | negative regulation of cell killing (GO:0031342) | 3.99025654 |
| 29 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.99025654 |
| 30 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.98107868 |
| 31 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.97620548 |
| 32 | oligosaccharide catabolic process (GO:0009313) | 3.96775949 |
| 33 | positive regulation of lipid catabolic process (GO:0050996) | 3.95832931 |
| 34 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.91072973 |
| 35 | N-acetylneuraminate metabolic process (GO:0006054) | 3.90047452 |
| 36 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.87326673 |
| 37 | detection of molecule of bacterial origin (GO:0032490) | 3.86193591 |
| 38 | positive regulation of mast cell degranulation (GO:0043306) | 3.78063837 |
| 39 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.78063837 |
| 40 | carnitine transmembrane transport (GO:1902603) | 3.77402250 |
| 41 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.74830192 |
| 42 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.74830192 |
| 43 | modulation by symbiont of host immune response (GO:0052553) | 3.74830192 |
| 44 | positive regulation by symbiont of host defense response (GO:0052509) | 3.74830192 |
| 45 | modulation by symbiont of host defense response (GO:0052031) | 3.74830192 |
| 46 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.74830192 |
| 47 | regulation of leukocyte degranulation (GO:0043300) | 3.73845031 |
| 48 | fatty acid oxidation (GO:0019395) | 3.73471872 |
| 49 | lipid oxidation (GO:0034440) | 3.71416159 |
| 50 | positive regulation of mast cell activation (GO:0033005) | 3.70504828 |
| 51 | glycolipid catabolic process (GO:0019377) | 3.69899693 |
| 52 | fatty acid catabolic process (GO:0009062) | 3.69761581 |
| 53 | regulation of triglyceride catabolic process (GO:0010896) | 3.66875751 |
| 54 | 2-oxoglutarate metabolic process (GO:0006103) | 3.63859074 |
| 55 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.63150044 |
| 56 | acetyl-CoA metabolic process (GO:0006084) | 3.60985006 |
| 57 | barbed-end actin filament capping (GO:0051016) | 3.60888943 |
| 58 | branched-chain amino acid metabolic process (GO:0009081) | 3.59563285 |
| 59 | response to dietary excess (GO:0002021) | 3.57560191 |
| 60 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.57022459 |
| 61 | L-phenylalanine catabolic process (GO:0006559) | 3.57022459 |
| 62 | white fat cell differentiation (GO:0050872) | 3.56509040 |
| 63 | oxaloacetate metabolic process (GO:0006107) | 3.54984686 |
| 64 | positive regulation of leukocyte degranulation (GO:0043302) | 3.53787913 |
| 65 | response to muramyl dipeptide (GO:0032495) | 3.53762003 |
| 66 | sulfur amino acid catabolic process (GO:0000098) | 3.52928212 |
| 67 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.52184191 |
| 68 | amino-acid betaine transport (GO:0015838) | 3.50606915 |
| 69 | carnitine transport (GO:0015879) | 3.50606915 |
| 70 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.50466355 |
| 71 | branched-chain amino acid catabolic process (GO:0009083) | 3.50433775 |
| 72 | triglyceride biosynthetic process (GO:0019432) | 3.47697354 |
| 73 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.46218798 |
| 74 | L-phenylalanine metabolic process (GO:0006558) | 3.46218798 |
| 75 | phospholipid homeostasis (GO:0055091) | 3.44791906 |
| 76 | macrophage activation (GO:0042116) | 3.44056282 |
| 77 | positive regulation of fatty acid metabolic process (GO:0045923) | 3.43444478 |
| 78 | triglyceride metabolic process (GO:0006641) | 3.42779879 |
| 79 | regulation of fatty acid oxidation (GO:0046320) | 3.41865578 |
| 80 | glycerolipid catabolic process (GO:0046503) | 3.39656457 |
| 81 | triglyceride homeostasis (GO:0070328) | 3.38982748 |
| 82 | acylglycerol homeostasis (GO:0055090) | 3.38982748 |
| 83 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.38938230 |
| 84 | neutral lipid biosynthetic process (GO:0046460) | 3.36830757 |
| 85 | acylglycerol biosynthetic process (GO:0046463) | 3.36830757 |
| 86 | regulation of mast cell activation (GO:0033003) | 3.35534905 |
| 87 | detection of other organism (GO:0098543) | 3.34565285 |
| 88 | detection of external biotic stimulus (GO:0098581) | 3.31796441 |
| 89 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 3.31506690 |
| 90 | thioester biosynthetic process (GO:0035384) | 3.30441468 |
| 91 | acyl-CoA biosynthetic process (GO:0071616) | 3.30441468 |
| 92 | positive regulation of extracellular matrix organization (GO:1903055) | 3.26471329 |
| 93 | acylglycerol metabolic process (GO:0006639) | 3.25033906 |
| 94 | monocarboxylic acid catabolic process (GO:0072329) | 3.24519993 |
| 95 | fatty-acyl-CoA metabolic process (GO:0035337) | 3.22952397 |
| 96 | cellular extravasation (GO:0045123) | 3.22213174 |
| 97 | adenosine receptor signaling pathway (GO:0001973) | 3.20686209 |
| 98 | neutral lipid metabolic process (GO:0006638) | 3.20484191 |
| 99 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 3.20031754 |
| 100 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.19431695 |
| 101 | ceramide catabolic process (GO:0046514) | 3.19231079 |
| 102 | lipid storage (GO:0019915) | 3.18112042 |
| 103 | positive regulation of sterol transport (GO:0032373) | 3.16361620 |
| 104 | positive regulation of cholesterol transport (GO:0032376) | 3.16361620 |
| 105 | intracellular lipid transport (GO:0032365) | 3.13249656 |
| 106 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.13205441 |
| 107 | regulation of superoxide anion generation (GO:0032928) | 3.12976738 |
| 108 | microglial cell activation (GO:0001774) | 3.12948642 |
| 109 | granulocyte activation (GO:0036230) | 3.12613923 |
| 110 | positive regulation of cholesterol efflux (GO:0010875) | 3.10110570 |
| 111 | tricarboxylic acid metabolic process (GO:0072350) | 3.09045224 |
| 112 | regulation of mononuclear cell migration (GO:0071675) | 3.06242740 |
| 113 | response to thyroid hormone (GO:0097066) | 3.05027437 |
| 114 | phospholipid efflux (GO:0033700) | 3.04854979 |
| 115 | immunoglobulin mediated immune response (GO:0016064) | 3.04438914 |
| 116 | succinate metabolic process (GO:0006105) | 3.04156906 |
| 117 | neutrophil activation (GO:0042119) | 3.03788237 |
| 118 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.01813105 |
| 119 | negative regulation of granulocyte differentiation (GO:0030853) | 3.01619795 |
| 120 | regulation of macrophage chemotaxis (GO:0010758) | 3.01332242 |
| 121 | epithelial cell differentiation involved in prostate gland development (GO:0060742) | 3.01291586 |
| 122 | glycogen catabolic process (GO:0005980) | 3.00163034 |
| 123 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.99693331 |
| 124 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.99419953 |
| 125 | detection of biotic stimulus (GO:0009595) | 2.98413119 |
| 126 | long-chain fatty-acyl-CoA biosynthetic process (GO:0035338) | 2.97677296 |
| 127 | negative regulation of protein autophosphorylation (GO:0031953) | 2.97426783 |
| 128 | amino-acid betaine metabolic process (GO:0006577) | 2.97304025 |
| 129 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.96323571 |
| 130 | lipid particle organization (GO:0034389) | 2.95553906 |
| 131 | detection of bacterium (GO:0016045) | 2.94116640 |
| 132 | carnitine metabolic process (GO:0009437) | 2.93925202 |
| 133 | long-chain fatty-acyl-CoA metabolic process (GO:0035336) | 2.93695218 |
| 134 | urea metabolic process (GO:0019627) | 2.93384412 |
| 135 | urea cycle (GO:0000050) | 2.93384412 |
| 136 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.92890159 |
| 137 | germinal center formation (GO:0002467) | 2.90984453 |
| 138 | regulation of sterol transport (GO:0032371) | 2.90171755 |
| 139 | regulation of cholesterol transport (GO:0032374) | 2.90171755 |
| 140 | reverse cholesterol transport (GO:0043691) | 2.88815611 |
| 141 | regulation of protein activation cascade (GO:2000257) | 2.88188370 |
| 142 | short-chain fatty acid metabolic process (GO:0046459) | 2.87903577 |
| 143 | glucan catabolic process (GO:0009251) | 2.87193075 |
| 144 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.85941039 |
| 145 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.85751920 |
| 146 | regulation of complement activation (GO:0030449) | 2.84574642 |
| 147 | protein-lipid complex remodeling (GO:0034368) | 2.83583254 |
| 148 | macromolecular complex remodeling (GO:0034367) | 2.83583254 |
| 149 | plasma lipoprotein particle remodeling (GO:0034369) | 2.83583254 |
| 150 | regulation of triglyceride metabolic process (GO:0090207) | 2.83005488 |
| 151 | regulation of regulated secretory pathway (GO:1903305) | 2.80897278 |
| 152 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.79183402 |
| 153 | high-density lipoprotein particle remodeling (GO:0034375) | 2.78707322 |
| 154 | positive regulation of lipid storage (GO:0010884) | 2.78244950 |
| 155 | myeloid cell activation involved in immune response (GO:0002275) | 2.76161831 |
| 156 | acyl-CoA metabolic process (GO:0006637) | 2.75812409 |
| 157 | thioester metabolic process (GO:0035383) | 2.75812409 |
| 158 | positive regulation of macrophage cytokine production (GO:0060907) | 2.75709279 |
| 159 | negative regulation of lipid storage (GO:0010888) | 2.75611783 |
| 160 | nitrogen cycle metabolic process (GO:0071941) | 2.75529550 |
| 161 | regulation of cholesterol esterification (GO:0010872) | 2.74890827 |
| 162 | lipoprotein transport (GO:0042953) | 2.74428974 |
| 163 | coenzyme A biosynthetic process (GO:0015937) | 2.74014049 |
| 164 | lysine catabolic process (GO:0006554) | 2.72864391 |
| 165 | lysine metabolic process (GO:0006553) | 2.72864391 |
| 166 | regulation of gamma-delta T cell activation (GO:0046643) | 2.68031644 |
| 167 | T-helper 1 type immune response (GO:0042088) | 2.65508330 |
| 168 | membrane lipid catabolic process (GO:0046466) | 2.64829419 |
| 169 | respiratory burst (GO:0045730) | 2.62564344 |
| 170 | macrophage differentiation (GO:0030225) | 2.61650529 |
| 171 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.59687813 |
| 172 | regulation of macrophage cytokine production (GO:0010935) | 2.59274975 |
| 173 | chondroitin sulfate catabolic process (GO:0030207) | 2.58048517 |
| 174 | sphingolipid catabolic process (GO:0030149) | 2.56758690 |
| 175 | cellular response to arsenic-containing substance (GO:0071243) | 2.55187625 |
| 176 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.49803961 |
| 177 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.48617970 |
| 178 | neutrophil chemotaxis (GO:0030593) | 2.47510143 |
| 179 | regulation of beta-amyloid formation (GO:1902003) | 2.47134561 |
| 180 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.43842531 |
| 181 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.42301464 |
| 182 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.41710537 |
| 183 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.41093122 |
| 184 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.41093122 |
| 185 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.40582293 |
| 186 | neutrophil migration (GO:1990266) | 2.39831609 |
| 187 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.38879546 |
| 188 | response to host immune response (GO:0052572) | 2.38748859 |
| 189 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.38748859 |
| 190 | pinocytosis (GO:0006907) | 2.38415479 |
| 191 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.37996885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 9.50524688 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 6.10604077 |
| 3 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.60861777 |
| 4 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 4.15981141 |
| 5 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.92960810 |
| 6 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.88777878 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.41851463 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.89100326 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.71973926 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.50040295 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.46165782 |
| 12 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.35416159 |
| 13 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.34606417 |
| 14 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.23287539 |
| 15 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.22830432 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.17779249 |
| 17 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.08461289 |
| 18 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 2.07923371 |
| 19 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 2.00268046 |
| 20 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88514652 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.84966274 |
| 22 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.78721130 |
| 23 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.78713525 |
| 24 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.77627725 |
| 25 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.74225267 |
| 26 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.73342805 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.73340339 |
| 28 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.72881119 |
| 29 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.70178681 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.69895447 |
| 31 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.66638804 |
| 32 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.61239783 |
| 33 | * NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.61017400 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.58398192 |
| 35 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.56691343 |
| 36 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.56684552 |
| 37 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.55168903 |
| 38 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.54293008 |
| 39 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.52260967 |
| 40 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.51157686 |
| 41 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.50156152 |
| 42 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.48264414 |
| 43 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.47972587 |
| 44 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46638689 |
| 45 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45137578 |
| 46 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.41075523 |
| 47 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.40875075 |
| 48 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.40730230 |
| 49 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.39088309 |
| 50 | MAF_26560356_Chip-Seq_TH1_Human | 1.38091730 |
| 51 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.35242224 |
| 52 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.33746304 |
| 53 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.33645238 |
| 54 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.32920826 |
| 55 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.32526451 |
| 56 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31332134 |
| 57 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.28662561 |
| 58 | MYC_22102868_ChIP-Seq_BL_Human | 1.28038773 |
| 59 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.27297243 |
| 60 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.24296228 |
| 61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23611681 |
| 62 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22969573 |
| 63 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.21585509 |
| 64 | KDM2B_26808549_Chip-Seq_K562_Human | 1.21189380 |
| 65 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20776392 |
| 66 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.19612369 |
| 67 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.18707253 |
| 68 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16899402 |
| 69 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.15858898 |
| 70 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.14125610 |
| 71 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.14125610 |
| 72 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.13075232 |
| 73 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13009370 |
| 74 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12824154 |
| 75 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.12052333 |
| 76 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.12038911 |
| 77 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.11179867 |
| 78 | UTX_26944678_Chip-Seq_JUKART_Human | 1.11107738 |
| 79 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.10640869 |
| 80 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10458083 |
| 81 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.10404917 |
| 82 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.09483937 |
| 83 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.09420304 |
| 84 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.09420304 |
| 85 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08687521 |
| 86 | * PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08427481 |
| 87 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.06014739 |
| 88 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.05658757 |
| 89 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.04777616 |
| 90 | MAF_26560356_Chip-Seq_TH2_Human | 1.04272413 |
| 91 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.03171059 |
| 92 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.02178761 |
| 93 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01415952 |
| 94 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.00058308 |
| 95 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 0.99652955 |
| 96 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.99586716 |
| 97 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.98157408 |
| 98 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.97024760 |
| 99 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.96714986 |
| 100 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.96701132 |
| 101 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.96405612 |
| 102 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.95082156 |
| 103 | * BCOR_27268052_Chip-Seq_Bcells_Human | 0.94617929 |
| 104 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.94588978 |
| 105 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.94030083 |
| 106 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92857718 |
| 107 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.92167938 |
| 108 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89469122 |
| 109 | * PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.89041983 |
| 110 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.88908435 |
| 111 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.88292849 |
| 112 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.88132398 |
| 113 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.87880520 |
| 114 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.86598037 |
| 115 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.84081924 |
| 116 | GATA1_19941826_ChIP-Seq_K562_Human | 0.82910815 |
| 117 | * PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.81977109 |
| 118 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81966976 |
| 119 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.81186203 |
| 120 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.80791752 |
| 121 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.80097155 |
| 122 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79034087 |
| 123 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.77342002 |
| 124 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.76961566 |
| 125 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.76482669 |
| 126 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.75543058 |
| 127 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.75312329 |
| 128 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.74048779 |
| 129 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.72239880 |
| 130 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.71323823 |
| 131 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.69300345 |
| 132 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69014059 |
| 133 | SPI1_23127762_ChIP-Seq_K562_Human | 0.68402664 |
| 134 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.68396331 |
| 135 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.66684048 |
| 136 | * PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.66224276 |
| 137 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.66211327 |
| 138 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.66071230 |
| 139 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.65895536 |
| 140 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.65895536 |
| 141 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65881116 |
| 142 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.65050053 |
| 143 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.64469558 |
| 144 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.63960452 |
| 145 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.63353962 |
| 146 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.63200171 |
| 147 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.63130043 |
| 148 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.62909919 |
| 149 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.62846345 |
| 150 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.61906519 |
| 151 | AR_25329375_ChIP-Seq_VCAP_Human | 0.61903627 |
| 152 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.61822741 |
| 153 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.60817703 |
| 154 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.59499703 |
| 155 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.59466776 |
| 156 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.59448044 |
| 157 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.59204606 |
| 158 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.58895300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 5.03944377 |
| 2 | MP0004130_abnormal_muscle_cell | 4.12135045 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 3.89378878 |
| 4 | MP0002837_dystrophic_cardiac_calcinosis | 3.48445442 |
| 5 | MP0005360_urolithiasis | 3.38071442 |
| 6 | MP0005666_abnormal_adipose_tissue | 3.35580456 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.29786667 |
| 8 | MP0003303_peritoneal_inflammation | 3.15818480 |
| 9 | MP0005365_abnormal_bile_salt | 3.11108067 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.92352548 |
| 11 | MP0003172_abnormal_lysosome_physiology | 2.80028993 |
| 12 | MP0004185_abnormal_adipocyte_glucose | 2.79646943 |
| 13 | MP0002419_abnormal_innate_immunity | 2.73250958 |
| 14 | MP0006082_CNS_inflammation | 2.61807427 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.53784969 |
| 16 | MP0002876_abnormal_thyroid_physiology | 2.45644128 |
| 17 | MP0005375_adipose_tissue_phenotype | 2.39402273 |
| 18 | MP0005085_abnormal_gallbladder_physiolo | 2.35323503 |
| 19 | MP0002971_abnormal_brown_adipose | 2.25020315 |
| 20 | MP0003646_muscle_fatigue | 2.20557597 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 2.18826888 |
| 22 | MP0002148_abnormal_hypersensitivity_rea | 2.17162638 |
| 23 | MP0009840_abnormal_foam_cell | 2.09851711 |
| 24 | MP0005334_abnormal_fat_pad | 2.08861768 |
| 25 | MP0000685_abnormal_immune_system | 2.08418477 |
| 26 | MP0000013_abnormal_adipose_tissue | 2.07336300 |
| 27 | MP0008875_abnormal_xenobiotic_pharmacok | 2.04874103 |
| 28 | MP0005025_abnormal_response_to | 2.03214891 |
| 29 | MP0000751_myopathy | 2.01440163 |
| 30 | MP0000749_muscle_degeneration | 1.95888963 |
| 31 | MP0009115_abnormal_fat_cell | 1.89704794 |
| 32 | MP0005000_abnormal_immune_tolerance | 1.88503541 |
| 33 | MP0001835_abnormal_antigen_presentation | 1.83401414 |
| 34 | MP0002998_abnormal_bone_remodeling | 1.83070065 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.82581080 |
| 36 | MP0009785_altered_susceptibility_to | 1.82211543 |
| 37 | MP0005387_immune_system_phenotype | 1.80096226 |
| 38 | MP0001790_abnormal_immune_system | 1.80096226 |
| 39 | MP0004510_myositis | 1.78839990 |
| 40 | MP0003690_abnormal_glial_cell | 1.76310480 |
| 41 | MP0002452_abnormal_antigen_presenting | 1.76283678 |
| 42 | MP0003183_abnormal_peptide_metabolism | 1.72658625 |
| 43 | MP0005451_abnormal_body_composition | 1.71462663 |
| 44 | MP0002723_abnormal_immune_serum | 1.71083730 |
| 45 | MP0000609_abnormal_liver_physiology | 1.66638344 |
| 46 | MP0005535_abnormal_body_temperature | 1.66139735 |
| 47 | MP0009278_abnormal_bone_marrow | 1.64470590 |
| 48 | MP0008438_abnormal_cutaneous_collagen | 1.62964470 |
| 49 | MP0003806_abnormal_nucleotide_metabolis | 1.62230554 |
| 50 | MP0005671_abnormal_response_to | 1.58818931 |
| 51 | MP0004036_abnormal_muscle_relaxation | 1.55471035 |
| 52 | MP0004145_abnormal_muscle_electrophysio | 1.53780735 |
| 53 | MP0001800_abnormal_humoral_immune | 1.53487032 |
| 54 | MP0008260_abnormal_autophagy | 1.52461615 |
| 55 | MP0003252_abnormal_bile_duct | 1.51945619 |
| 56 | MP0002420_abnormal_adaptive_immunity | 1.51822161 |
| 57 | MP0000003_abnormal_adipose_tissue | 1.49933914 |
| 58 | MP0001819_abnormal_immune_cell | 1.49376056 |
| 59 | MP0000920_abnormal_myelination | 1.48617714 |
| 60 | MP0005319_abnormal_enzyme/_coenzyme | 1.42000427 |
| 61 | MP0002405_respiratory_system_inflammati | 1.41971513 |
| 62 | MP0006036_abnormal_mitochondrial_physio | 1.41019957 |
| 63 | MP0003186_abnormal_redox_activity | 1.38915990 |
| 64 | MP0003705_abnormal_hypodermis_morpholog | 1.38456169 |
| 65 | MP0003724_increased_susceptibility_to | 1.38452382 |
| 66 | MP0005332_abnormal_amino_acid | 1.37967308 |
| 67 | MP0005166_decreased_susceptibility_to | 1.37451378 |
| 68 | MP0005083_abnormal_biliary_tract | 1.37039523 |
| 69 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.36558068 |
| 70 | MP0001986_abnormal_taste_sensitivity | 1.34777367 |
| 71 | MP0005464_abnormal_platelet_physiology | 1.34493676 |
| 72 | MP0001845_abnormal_inflammatory_respons | 1.33064785 |
| 73 | MP0004087_abnormal_muscle_fiber | 1.31448910 |
| 74 | MP0005448_abnormal_energy_balance | 1.29636838 |
| 75 | MP0005620_abnormal_muscle_contractility | 1.29310260 |
| 76 | MP0002970_abnormal_white_adipose | 1.27680006 |
| 77 | MP0004147_increased_porphyrin_level | 1.26083338 |
| 78 | MP0000343_altered_response_to | 1.23753569 |
| 79 | MP0001661_extended_life_span | 1.21899939 |
| 80 | MP0000604_amyloidosis | 1.21585116 |
| 81 | MP0005058_abnormal_lysosome_morphology | 1.21404721 |
| 82 | MP0003828_pulmonary_edema | 1.20828743 |
| 83 | MP0001764_abnormal_homeostasis | 1.20818490 |
| 84 | MP0002078_abnormal_glucose_homeostasis | 1.20165626 |
| 85 | MP0000858_altered_metastatic_potential | 1.18522467 |
| 86 | MP0000759_abnormal_skeletal_muscle | 1.18228730 |
| 87 | MP0002735_abnormal_chemical_nociception | 1.16234279 |
| 88 | MP0004858_abnormal_nervous_system | 1.15449740 |
| 89 | MP0004947_skin_inflammation | 1.14039747 |
| 90 | MP0001666_abnormal_nutrient_absorption | 1.13516077 |
| 91 | MP0000465_gastrointestinal_hemorrhage | 1.13213811 |
| 92 | MP0000747_muscle_weakness | 1.11440179 |
| 93 | MP0004233_abnormal_muscle_weight | 1.10875051 |
| 94 | MP0005310_abnormal_salivary_gland | 1.10443809 |
| 95 | MP0002332_abnormal_exercise_endurance | 1.10137280 |
| 96 | MP0003634_abnormal_glial_cell | 1.09384536 |
| 97 | MP0002653_abnormal_ependyma_morphology | 1.08246682 |
| 98 | MP0010155_abnormal_intestine_physiology | 1.07056620 |
| 99 | MP0003656_abnormal_erythrocyte_physiolo | 1.05455073 |
| 100 | MP0003959_abnormal_lean_body | 1.05412215 |
| 101 | MP0000750_abnormal_muscle_regeneration | 1.05057174 |
| 102 | MP0002269_muscular_atrophy | 1.04666051 |
| 103 | MP0003453_abnormal_keratinocyte_physiol | 1.02407366 |
| 104 | MP0003075_altered_response_to | 1.01295234 |
| 105 | MP0002106_abnormal_muscle_physiology | 0.99515952 |
| 106 | MP0005397_hematopoietic_system_phenotyp | 0.99183667 |
| 107 | MP0001545_abnormal_hematopoietic_system | 0.99183667 |
| 108 | MP0002254_reproductive_system_inflammat | 0.97300984 |
| 109 | MP0005275_abnormal_skin_tensile | 0.96536409 |
| 110 | MP0002277_abnormal_respiratory_mucosa | 0.96328131 |
| 111 | MP0000716_abnormal_immune_system | 0.95885223 |
| 112 | MP0002972_abnormal_cardiac_muscle | 0.94305448 |
| 113 | MP0006276_abnormal_autonomic_nervous | 0.92022096 |
| 114 | MP0003329_amyloid_beta_deposits | 0.90165496 |
| 115 | MP0003633_abnormal_nervous_system | 0.90022350 |
| 116 | MP0002909_abnormal_adrenal_gland | 0.89867271 |
| 117 | MP0000249_abnormal_blood_vessel | 0.89611089 |
| 118 | MP0008004_abnormal_stomach_pH | 0.89339978 |
| 119 | MP0003448_altered_tumor_morphology | 0.89056034 |
| 120 | MP0004215_abnormal_myocardial_fiber | 0.88931751 |
| 121 | MP0008775_abnormal_heart_ventricle | 0.87778840 |
| 122 | MP0005452_abnormal_adipose_tissue | 0.87557829 |
| 123 | MP0009780_abnormal_chondrocyte_physiolo | 0.87068211 |
| 124 | MP0005330_cardiomyopathy | 0.84932520 |
| 125 | MP0009333_abnormal_splenocyte_physiolog | 0.84628707 |
| 126 | MP0001851_eye_inflammation | 0.83983855 |
| 127 | MP0009764_decreased_sensitivity_to | 0.83971818 |
| 128 | MP0005385_cardiovascular_system_phenoty | 0.83770032 |
| 129 | MP0001544_abnormal_cardiovascular_syste | 0.83770032 |
| 130 | MP0004270_analgesia | 0.83461625 |
| 131 | MP0009643_abnormal_urine_homeostasis | 0.81631406 |
| 132 | MP0001501_abnormal_sleep_pattern | 0.80426884 |
| 133 | MP0003045_fibrosis | 0.79263428 |
| 134 | MP0003091_abnormal_cell_migration | 0.78799752 |
| 135 | MP0003436_decreased_susceptibility_to | 0.77681312 |
| 136 | MP0005390_skeleton_phenotype | 0.76096979 |
| 137 | MP0000230_abnormal_systemic_arterial | 0.76084275 |
| 138 | MP0000689_abnormal_spleen_morphology | 0.74769003 |
| 139 | MP0008961_abnormal_basal_metabolism | 0.74708339 |
| 140 | MP0003011_delayed_dark_adaptation | 0.74666527 |
| 141 | MP0006138_congestive_heart_failure | 0.74415850 |
| 142 | MP0002733_abnormal_thermal_nociception | 0.73422169 |
| 143 | MP0005369_muscle_phenotype | 0.73301552 |
| 144 | MP0005595_abnormal_vascular_smooth | 0.72336009 |
| 145 | MP0002736_abnormal_nociception_after | 0.71217797 |
| 146 | MP0003795_abnormal_bone_structure | 0.70696193 |
| 147 | MP0001756_abnormal_urination | 0.70536936 |
| 148 | MP0009763_increased_sensitivity_to | 0.70063603 |
| 149 | MP0005164_abnormal_response_to | 0.69794091 |
| 150 | MP0003632_abnormal_nervous_system | 0.69395411 |
| 151 | MP0005165_increased_susceptibility_to | 0.68753410 |
| 152 | MP0001968_abnormal_touch/_nociception | 0.68657151 |
| 153 | MP0001853_heart_inflammation | 0.68522628 |
| 154 | MP0000598_abnormal_liver_morphology | 0.68417504 |
| 155 | MP0003279_aneurysm | 0.68389041 |
| 156 | MP0004883_abnormal_blood_vessel | 0.67036250 |
| 157 | MP0008469_abnormal_protein_level | 0.66975905 |
| 158 | MP0002398_abnormal_bone_marrow | 0.66285865 |
| 159 | MP0002933_joint_inflammation | 0.65920292 |
| 160 | MP0005167_abnormal_blood-brain_barrier | 0.63773810 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 6.98751668 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 6.98751668 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 6.98751668 |
| 4 | Oligomenorrhea (HP:0000876) | 5.29647401 |
| 5 | Increased cerebral lipofuscin (HP:0011813) | 5.12665052 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 5.08462197 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.55973007 |
| 8 | Complement deficiency (HP:0004431) | 4.47777062 |
| 9 | Eczematoid dermatitis (HP:0000976) | 4.46475371 |
| 10 | Dysostosis multiplex (HP:0000943) | 4.43579231 |
| 11 | Loss of speech (HP:0002371) | 4.17841422 |
| 12 | Recurrent abscess formation (HP:0002722) | 4.12643581 |
| 13 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.02978763 |
| 14 | Disinhibition (HP:0000734) | 3.99549457 |
| 15 | Exercise-induced myalgia (HP:0003738) | 3.93882274 |
| 16 | Myoglobinuria (HP:0002913) | 3.86856155 |
| 17 | Xanthomatosis (HP:0000991) | 3.85973950 |
| 18 | Hyperglycinuria (HP:0003108) | 3.85644781 |
| 19 | Neurofibrillary tangles (HP:0002185) | 3.84514271 |
| 20 | Hypertriglyceridemia (HP:0002155) | 3.78111951 |
| 21 | Hypoalphalipoproteinemia (HP:0003233) | 3.73799611 |
| 22 | Recurrent bacterial skin infections (HP:0005406) | 3.71457395 |
| 23 | Mutism (HP:0002300) | 3.67348575 |
| 24 | Acanthosis nigricans (HP:0000956) | 3.60278758 |
| 25 | Ketosis (HP:0001946) | 3.44206590 |
| 26 | Abnormality of glycine metabolism (HP:0010895) | 3.43847667 |
| 27 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.43847667 |
| 28 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.42706518 |
| 29 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.42706518 |
| 30 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.42706518 |
| 31 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.39739735 |
| 32 | Difficulty running (HP:0009046) | 3.39427221 |
| 33 | Deep venous thrombosis (HP:0002625) | 3.26581866 |
| 34 | Myotonia (HP:0002486) | 3.26351363 |
| 35 | Mediastinal lymphadenopathy (HP:0100721) | 3.25894773 |
| 36 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.25596355 |
| 37 | Mucopolysacchariduria (HP:0008155) | 3.25596355 |
| 38 | Hyperlipoproteinemia (HP:0010980) | 3.24119176 |
| 39 | Exercise-induced muscle cramps (HP:0003710) | 3.22272071 |
| 40 | Abnormality of complement system (HP:0005339) | 3.18331280 |
| 41 | Distal arthrogryposis (HP:0005684) | 3.14564377 |
| 42 | Hyporeflexia of lower limbs (HP:0002600) | 3.14423787 |
| 43 | Hyperammonemia (HP:0001987) | 3.11198950 |
| 44 | Rhabdomyolysis (HP:0003201) | 3.10032658 |
| 45 | Ketoacidosis (HP:0001993) | 3.04727136 |
| 46 | Hypolipoproteinemia (HP:0010981) | 3.03528676 |
| 47 | Systemic lupus erythematosus (HP:0002725) | 3.01340237 |
| 48 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.01131806 |
| 49 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.00840515 |
| 50 | Nuclear cataract (HP:0100018) | 3.00483328 |
| 51 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.98460195 |
| 52 | Muscle stiffness (HP:0003552) | 2.97908555 |
| 53 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.96961157 |
| 54 | Increased connective tissue (HP:0009025) | 2.94240339 |
| 55 | Hypercholesterolemia (HP:0003124) | 2.93620787 |
| 56 | Muscle fiber inclusion bodies (HP:0100299) | 2.93317814 |
| 57 | Hyperglycinemia (HP:0002154) | 2.93205218 |
| 58 | Spontaneous hematomas (HP:0007420) | 2.92033136 |
| 59 | Epidermoid cyst (HP:0200040) | 2.91700510 |
| 60 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.88369650 |
| 61 | Myositis (HP:0100614) | 2.84432737 |
| 62 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.78383839 |
| 63 | Asymmetric septal hypertrophy (HP:0001670) | 2.77813906 |
| 64 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.77593545 |
| 65 | Cerebral inclusion bodies (HP:0100314) | 2.77336790 |
| 66 | Hypoglycemic coma (HP:0001325) | 2.76646636 |
| 67 | Stomatitis (HP:0010280) | 2.75632196 |
| 68 | Orchitis (HP:0100796) | 2.74213598 |
| 69 | Facial diplegia (HP:0001349) | 2.71172300 |
| 70 | Calf muscle hypertrophy (HP:0008981) | 2.69705395 |
| 71 | Pigmentary retinal degeneration (HP:0001146) | 2.69310359 |
| 72 | Myocardial infarction (HP:0001658) | 2.67321669 |
| 73 | Muscle fiber splitting (HP:0003555) | 2.66919413 |
| 74 | Type 1 muscle fiber predominance (HP:0003803) | 2.64089371 |
| 75 | Nemaline bodies (HP:0003798) | 2.62011375 |
| 76 | Purpura (HP:0000979) | 2.59458683 |
| 77 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.58911131 |
| 78 | Hepatosplenomegaly (HP:0001433) | 2.58356538 |
| 79 | Intrahepatic cholestasis (HP:0001406) | 2.57255042 |
| 80 | Hemorrhage of the eye (HP:0011885) | 2.55800631 |
| 81 | Neuronal loss in central nervous system (HP:0002529) | 2.54524751 |
| 82 | Upper motor neuron abnormality (HP:0002127) | 2.53034782 |
| 83 | Gingivitis (HP:0000230) | 2.51922724 |
| 84 | Obstructive lung disease (HP:0006536) | 2.50748031 |
| 85 | Chronic obstructive pulmonary disease (HP:0006510) | 2.50748031 |
| 86 | Increased CSF protein (HP:0002922) | 2.50404873 |
| 87 | Cholelithiasis (HP:0001081) | 2.48749725 |
| 88 | Autoimmune thrombocytopenia (HP:0001973) | 2.44004912 |
| 89 | Abnormal gallbladder physiology (HP:0012438) | 2.41812062 |
| 90 | Cholecystitis (HP:0001082) | 2.41812062 |
| 91 | Abnormal gallbladder morphology (HP:0012437) | 2.41070866 |
| 92 | Retinal atrophy (HP:0001105) | 2.37443330 |
| 93 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.37089403 |
| 94 | Frequent falls (HP:0002359) | 2.36393029 |
| 95 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.35751224 |
| 96 | Palpitations (HP:0001962) | 2.33569287 |
| 97 | Nausea (HP:0002018) | 2.32572438 |
| 98 | Hypobetalipoproteinemia (HP:0003563) | 2.32092534 |
| 99 | Amyloidosis (HP:0011034) | 2.32017695 |
| 100 | Pathologic fracture (HP:0002756) | 2.30738795 |
| 101 | Retrobulbar optic neuritis (HP:0100654) | 2.30325302 |
| 102 | Optic neuritis (HP:0100653) | 2.30325302 |
| 103 | Skin nodule (HP:0200036) | 2.30268981 |
| 104 | Apathy (HP:0000741) | 2.29647454 |
| 105 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.29640348 |
| 106 | Axonal loss (HP:0003447) | 2.29388366 |
| 107 | Diminished motivation (HP:0000745) | 2.28650780 |
| 108 | Agnosia (HP:0010524) | 2.25805611 |
| 109 | Inappropriate behavior (HP:0000719) | 2.25009747 |
| 110 | Hydroxyprolinuria (HP:0003080) | 2.22140682 |
| 111 | Abnormality of proline metabolism (HP:0010907) | 2.22140682 |
| 112 | Dicarboxylic aciduria (HP:0003215) | 2.20983340 |
| 113 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.20983340 |
| 114 | Prolonged neonatal jaundice (HP:0006579) | 2.19387991 |
| 115 | Dementia (HP:0000726) | 2.17893397 |
| 116 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.17714038 |
| 117 | Joint hemorrhage (HP:0005261) | 2.16915781 |
| 118 | Peripheral demyelination (HP:0011096) | 2.15386111 |
| 119 | Abnormality of the periventricular white matter (HP:0002518) | 2.14184209 |
| 120 | Progressive neurologic deterioration (HP:0002344) | 2.13791975 |
| 121 | EMG: myopathic abnormalities (HP:0003458) | 2.13702239 |
| 122 | Prolonged partial thromboplastin time (HP:0003645) | 2.11967822 |
| 123 | Vertebral compression fractures (HP:0002953) | 2.11613994 |
| 124 | Pancreatitis (HP:0001733) | 2.10166091 |
| 125 | Abnormality of purine metabolism (HP:0004352) | 2.09633664 |
| 126 | Lipoatrophy (HP:0100578) | 2.07938080 |
| 127 | Increased serum ferritin (HP:0003281) | 2.06677922 |
| 128 | Increased muscle lipid content (HP:0009058) | 2.04658164 |
| 129 | Insulin resistance (HP:0000855) | 2.04403033 |
| 130 | Bone cyst (HP:0012062) | 2.02253658 |
| 131 | Recurrent skin infections (HP:0001581) | 2.01875478 |
| 132 | Cellulitis (HP:0100658) | 2.00441290 |
| 133 | Metabolic acidosis (HP:0001942) | 1.97823970 |
| 134 | Polyneuropathy (HP:0001271) | 1.97429901 |
| 135 | Bulbar palsy (HP:0001283) | 1.96137987 |
| 136 | Pulmonary infiltrates (HP:0002113) | 1.95676017 |
| 137 | Increased variability in muscle fiber diameter (HP:0003557) | 1.95398389 |
| 138 | Right ventricular cardiomyopathy (HP:0011663) | 1.94870553 |
| 139 | Growth hormone excess (HP:0000845) | 1.94839926 |
| 140 | Pheochromocytoma (HP:0002666) | 1.93254975 |
| 141 | Petechiae (HP:0000967) | 1.92859949 |
| 142 | Absent phalangeal crease (HP:0006109) | 1.92374559 |
| 143 | Urticaria (HP:0001025) | 1.91414004 |
| 144 | Supranuclear gaze palsy (HP:0000605) | 1.90067407 |
| 145 | Myopathic facies (HP:0002058) | 1.89733821 |
| 146 | Hyperglycemia (HP:0003074) | 1.89262514 |
| 147 | Late onset (HP:0003584) | 1.89233219 |
| 148 | Tetraparesis (HP:0002273) | 1.89105205 |
| 149 | Hematochezia (HP:0002573) | 1.88701464 |
| 150 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.88228462 |
| 151 | Personality changes (HP:0000751) | 1.88221085 |
| 152 | Hyperbilirubinemia (HP:0002904) | 1.86603448 |
| 153 | Meningitis (HP:0001287) | 1.86145248 |
| 154 | Basal ganglia calcification (HP:0002135) | 1.85251635 |
| 155 | Neuroendocrine neoplasm (HP:0100634) | 1.85126320 |
| 156 | Recurrent fungal infections (HP:0002841) | 1.82203612 |
| 157 | Sudden death (HP:0001699) | 1.82160504 |
| 158 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.82105193 |
| 159 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.79368851 |
| 160 | Abnormality of serum amino acid levels (HP:0003112) | 1.78675846 |
| 161 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.78618832 |
| 162 | Bone pain (HP:0002653) | 1.77795858 |
| 163 | Lethargy (HP:0001254) | 1.77160186 |
| 164 | Rapidly progressive (HP:0003678) | 1.76803613 |
| 165 | Abnormality of the common coagulation pathway (HP:0010990) | 1.76574097 |
| 166 | Thoracic kyphosis (HP:0002942) | 1.75906261 |
| 167 | Cerebral edema (HP:0002181) | 1.75669264 |
| 168 | Nephritis (HP:0000123) | 1.75352509 |
| 169 | Cardiomegaly (HP:0001640) | 1.75232623 |
| 170 | Glomerulonephritis (HP:0000099) | 1.74040382 |
| 171 | Hepatic necrosis (HP:0002605) | 1.73685438 |
| 172 | Hemiplegia (HP:0002301) | 1.72152269 |
| 173 | Neck muscle weakness (HP:0000467) | 1.71763607 |
| 174 | Sensorimotor neuropathy (HP:0007141) | 1.70599406 |
| 175 | Distal lower limb muscle weakness (HP:0009053) | 1.70026966 |
| 176 | Abnormality of nucleobase metabolism (HP:0010932) | 1.69715245 |
| 177 | Restrictive lung disease (HP:0002091) | 1.68307724 |
| 178 | Progressive visual loss (HP:0000529) | 1.68119576 |
| 179 | Global brain atrophy (HP:0002283) | 1.65683177 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 4.28401722 |
| 2 | TRIB3 | 3.85652512 |
| 3 | CAMK1D | 3.81326406 |
| 4 | BCKDK | 3.77566687 |
| 5 | SIK1 | 3.16578586 |
| 6 | PHKG2 | 2.90617664 |
| 7 | PHKG1 | 2.90617664 |
| 8 | CAMK1G | 2.63878208 |
| 9 | OBSCN | 2.63203995 |
| 10 | MAP3K11 | 2.25631936 |
| 11 | TTN | 2.20694165 |
| 12 | RIPK1 | 2.17814995 |
| 13 | MAP4K1 | 2.05892452 |
| 14 | CSK | 1.94873305 |
| 15 | FES | 1.87952500 |
| 16 | KSR2 | 1.81498181 |
| 17 | PRPF4B | 1.81459695 |
| 18 | MST1R | 1.79334853 |
| 19 | PINK1 | 1.71334521 |
| 20 | ERN1 | 1.70655944 |
| 21 | TNK2 | 1.69537720 |
| 22 | MAP3K3 | 1.65531201 |
| 23 | PIK3CA | 1.64962568 |
| 24 | PDK4 | 1.62388262 |
| 25 | PDK3 | 1.62388262 |
| 26 | FGR | 1.59924587 |
| 27 | CSF1R | 1.55249491 |
| 28 | ZAP70 | 1.52841186 |
| 29 | MAP2K4 | 1.50313247 |
| 30 | MAP3K13 | 1.46144971 |
| 31 | TYK2 | 1.45701832 |
| 32 | INSRR | 1.44384221 |
| 33 | TAOK1 | 1.43273550 |
| 34 | MAPK15 | 1.39350780 |
| 35 | FGFR4 | 1.37732332 |
| 36 | GRK7 | 1.37014871 |
| 37 | DDR2 | 1.33669593 |
| 38 | MAP2K1 | 1.33288163 |
| 39 | FGFR3 | 1.32788720 |
| 40 | PRKAA2 | 1.30610605 |
| 41 | NEK9 | 1.29067986 |
| 42 | TESK2 | 1.28235544 |
| 43 | MAP2K3 | 1.25678480 |
| 44 | MAP3K2 | 1.25454126 |
| 45 | GRK5 | 1.22287529 |
| 46 | TAOK2 | 1.18268683 |
| 47 | FRK | 1.13676712 |
| 48 | MARK2 | 1.11728353 |
| 49 | RET | 1.11316323 |
| 50 | NTRK1 | 1.10278136 |
| 51 | RIPK4 | 1.09742773 |
| 52 | DAPK2 | 1.09465492 |
| 53 | PKN2 | 1.07539573 |
| 54 | JAK1 | 1.07020062 |
| 55 | MYLK | 1.04338968 |
| 56 | IKBKE | 1.03146023 |
| 57 | PDK2 | 1.00144038 |
| 58 | ICK | 0.99318448 |
| 59 | HCK | 0.99198342 |
| 60 | SYK | 0.99077334 |
| 61 | MOS | 0.98983166 |
| 62 | PIK3CG | 0.96821953 |
| 63 | JAK2 | 0.95853623 |
| 64 | ARAF | 0.93613755 |
| 65 | TIE1 | 0.92809405 |
| 66 | LYN | 0.92499700 |
| 67 | PTK2B | 0.92125875 |
| 68 | MAPK12 | 0.90024165 |
| 69 | IKBKB | 0.88289322 |
| 70 | MAPK7 | 0.87779832 |
| 71 | CAMKK2 | 0.86643521 |
| 72 | CDC42BPA | 0.83761819 |
| 73 | EPHB1 | 0.82951941 |
| 74 | FER | 0.82716920 |
| 75 | PDPK1 | 0.78411447 |
| 76 | PRKD3 | 0.77532773 |
| 77 | TBK1 | 0.76282909 |
| 78 | PRKAA1 | 0.75454205 |
| 79 | TGFBR2 | 0.75242983 |
| 80 | PRKD2 | 0.75089460 |
| 81 | MAP3K14 | 0.73399701 |
| 82 | BTK | 0.72995211 |
| 83 | SGK3 | 0.70547453 |
| 84 | PRKG2 | 0.68938457 |
| 85 | EPHA3 | 0.68712975 |
| 86 | MAP3K7 | 0.68600309 |
| 87 | JAK3 | 0.67103139 |
| 88 | GRK6 | 0.66892782 |
| 89 | MAPK11 | 0.65530971 |
| 90 | PDK1 | 0.65362938 |
| 91 | MARK3 | 0.64991509 |
| 92 | SGK2 | 0.64974056 |
| 93 | PAK4 | 0.64518138 |
| 94 | CAMK4 | 0.63771295 |
| 95 | PRKCH | 0.63051183 |
| 96 | SIK3 | 0.62084492 |
| 97 | IRAK3 | 0.61209252 |
| 98 | CDK6 | 0.60820122 |
| 99 | MAP3K1 | 0.60069478 |
| 100 | PDGFRA | 0.58271213 |
| 101 | BLK | 0.57014383 |
| 102 | MAPKAPK3 | 0.56961044 |
| 103 | PRKACG | 0.56109182 |
| 104 | LCK | 0.55873889 |
| 105 | TESK1 | 0.55866363 |
| 106 | RPS6KC1 | 0.55084740 |
| 107 | RPS6KL1 | 0.55084740 |
| 108 | SGK494 | 0.55045670 |
| 109 | SGK223 | 0.55045670 |
| 110 | LRRK2 | 0.55018776 |
| 111 | MATK | 0.54550159 |
| 112 | IRAK1 | 0.54426676 |
| 113 | PTK6 | 0.53754665 |
| 114 | CDK9 | 0.53335066 |
| 115 | MINK1 | 0.52249917 |
| 116 | PKN1 | 0.51818588 |
| 117 | MAP3K5 | 0.50691241 |
| 118 | RPS6KA2 | 0.50279081 |
| 119 | KSR1 | 0.49800133 |
| 120 | FGFR2 | 0.48630512 |
| 121 | PRKD1 | 0.48153273 |
| 122 | ACVR1B | 0.47696020 |
| 123 | IRAK2 | 0.47571618 |
| 124 | NME2 | 0.47412576 |
| 125 | FLT3 | 0.47315830 |
| 126 | LIMK1 | 0.47094130 |
| 127 | STK10 | 0.46843215 |
| 128 | ABL2 | 0.45745941 |
| 129 | IGF1R | 0.45180900 |
| 130 | ROCK2 | 0.44626008 |
| 131 | MET | 0.44457570 |
| 132 | TXK | 0.43143866 |
| 133 | MAP2K6 | 0.42451519 |
| 134 | MAP3K6 | 0.39779925 |
| 135 | MAP2K2 | 0.39425127 |
| 136 | STK24 | 0.39177058 |
| 137 | IRAK4 | 0.37574484 |
| 138 | MAPK4 | 0.36570550 |
| 139 | CAMKK1 | 0.35950413 |
| 140 | NEK1 | 0.35668898 |
| 141 | GSK3A | 0.35214818 |
| 142 | MAP3K9 | 0.34570964 |
| 143 | LATS2 | 0.34071281 |
| 144 | CAMK1 | 0.33717804 |
| 145 | KIT | 0.33212222 |
| 146 | ERBB4 | 0.31596792 |
| 147 | MAP3K12 | 0.30943244 |
| 148 | TRPM7 | 0.30370321 |
| 149 | EPHB2 | 0.30305683 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 4.51402343 |
| 2 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.20582131 |
| 3 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.20010686 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 3.01802530 |
| 5 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.92787120 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.74262444 |
| 7 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.58708359 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.58643796 |
| 9 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.44640237 |
| 10 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 2.43473735 |
| 11 | Leishmaniasis_Homo sapiens_hsa05140 | 2.41300757 |
| 12 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.38752063 |
| 13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.33013317 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.29873125 |
| 15 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.10721255 |
| 16 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.08155175 |
| 17 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.05274886 |
| 18 | Tuberculosis_Homo sapiens_hsa05152 | 2.02963403 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.02385499 |
| 20 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.01511577 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.94545680 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.88299021 |
| 23 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.87506201 |
| 24 | Peroxisome_Homo sapiens_hsa04146 | 1.87044041 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.86259278 |
| 26 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.83208353 |
| 27 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.82376440 |
| 28 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.77707250 |
| 29 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.75143440 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.71380830 |
| 31 | Malaria_Homo sapiens_hsa05144 | 1.67561728 |
| 32 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.64230440 |
| 33 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.63651814 |
| 34 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.62360458 |
| 35 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.61503326 |
| 36 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.60779845 |
| 37 | Carbon metabolism_Homo sapiens_hsa01200 | 1.60586688 |
| 38 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.55284551 |
| 39 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.51169299 |
| 40 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.45511714 |
| 41 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.41876818 |
| 42 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.41032744 |
| 43 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.40691386 |
| 44 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.31143672 |
| 45 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.29078977 |
| 46 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.28021303 |
| 47 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.26587498 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 1.26094617 |
| 49 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.24145985 |
| 50 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.23734897 |
| 51 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23604737 |
| 52 | Salmonella infection_Homo sapiens_hsa05132 | 1.23565655 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.21779268 |
| 54 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.19701382 |
| 55 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.17909063 |
| 56 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.15189709 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 1.14128455 |
| 58 | Allograft rejection_Homo sapiens_hsa05330 | 1.13259531 |
| 59 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.12869124 |
| 60 | Insulin resistance_Homo sapiens_hsa04931 | 1.12373900 |
| 61 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.12062332 |
| 62 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.11953958 |
| 63 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.11217795 |
| 64 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.11191475 |
| 65 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.11126574 |
| 66 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07137073 |
| 67 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.06653894 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.03046757 |
| 69 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.02462978 |
| 70 | Bile secretion_Homo sapiens_hsa04976 | 0.99230014 |
| 71 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.98988202 |
| 72 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98392347 |
| 73 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.97730537 |
| 74 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.93106494 |
| 75 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.93073463 |
| 76 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.92586653 |
| 77 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.91676860 |
| 78 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.91354369 |
| 79 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.91042395 |
| 80 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.89360108 |
| 81 | Influenza A_Homo sapiens_hsa05164 | 0.88250297 |
| 82 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.85428602 |
| 83 | Asthma_Homo sapiens_hsa05310 | 0.83755901 |
| 84 | Viral myocarditis_Homo sapiens_hsa05416 | 0.83345107 |
| 85 | Histidine metabolism_Homo sapiens_hsa00340 | 0.83268718 |
| 86 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.82527333 |
| 87 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.81493024 |
| 88 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.81357133 |
| 89 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.81162229 |
| 90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.81114169 |
| 91 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.79244852 |
| 92 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.78955371 |
| 93 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.78297497 |
| 94 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.77984791 |
| 95 | Hepatitis C_Homo sapiens_hsa05160 | 0.77142022 |
| 96 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.76925274 |
| 97 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.76675016 |
| 98 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.76378456 |
| 99 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.75803620 |
| 100 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70341641 |
| 101 | Shigellosis_Homo sapiens_hsa05131 | 0.69295979 |
| 102 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.65864323 |
| 103 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.64700856 |
| 104 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.64290694 |
| 105 | Measles_Homo sapiens_hsa05162 | 0.63976739 |
| 106 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.63607649 |
| 107 | Retinol metabolism_Homo sapiens_hsa00830 | 0.63553830 |
| 108 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.63420182 |
| 109 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.63327479 |
| 110 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.62118358 |
| 111 | Amoebiasis_Homo sapiens_hsa05146 | 0.61173740 |
| 112 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60551849 |
| 113 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.60060089 |
| 114 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.60032288 |
| 115 | Endocytosis_Homo sapiens_hsa04144 | 0.58981710 |
| 116 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.58783080 |
| 117 | Hepatitis B_Homo sapiens_hsa05161 | 0.57128246 |
| 118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.56953361 |
| 119 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.55943947 |
| 120 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55813871 |
| 121 | Galactose metabolism_Homo sapiens_hsa00052 | 0.55728036 |
| 122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55133354 |
| 123 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.53856777 |
| 124 | Apoptosis_Homo sapiens_hsa04210 | 0.53770573 |
| 125 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.53160426 |
| 126 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.52071844 |
| 127 | Platelet activation_Homo sapiens_hsa04611 | 0.51768046 |
| 128 | Bladder cancer_Homo sapiens_hsa05219 | 0.51389799 |
| 129 | Mineral absorption_Homo sapiens_hsa04978 | 0.50898361 |
| 130 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.50775152 |
| 131 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.47446599 |
| 132 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.47116368 |
| 133 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46808874 |
| 134 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.45593127 |
| 135 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44995095 |
| 136 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.44471004 |
| 137 | Renin secretion_Homo sapiens_hsa04924 | 0.44314949 |
| 138 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.44219935 |
| 139 | Endometrial cancer_Homo sapiens_hsa05213 | 0.43873097 |
| 140 | Sulfur relay system_Homo sapiens_hsa04122 | 0.40211601 |
| 141 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.39005714 |
| 142 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.38827404 |
| 143 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.38433629 |
| 144 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38284332 |
| 145 | Lysosome_Homo sapiens_hsa04142 | 0.36157175 |
| 146 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.35023070 |
| 147 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33578876 |
| 148 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.32967935 |
| 149 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.32353796 |
| 150 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.30848432 |
| 151 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.30323580 |
| 152 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.30001456 |
| 153 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.29659157 |
| 154 | Prion diseases_Homo sapiens_hsa05020 | 0.28792679 |
| 155 | Pertussis_Homo sapiens_hsa05133 | 0.27466327 |
| 156 | Metabolic pathways_Homo sapiens_hsa01100 | 0.27160976 |
| 157 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.26271572 |
| 158 | Lysine degradation_Homo sapiens_hsa00310 | 0.25546346 |
| 159 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.24896331 |
| 160 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.22424081 |
| 161 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.22055951 |
| 162 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.21762196 |
| 163 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.20176944 |
| 164 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.20100111 |
| 165 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.19822500 |
| 166 | Alzheimers disease_Homo sapiens_hsa05010 | 0.16675592 |
| 167 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.15863013 |
| 168 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.15671752 |
| 169 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.15544120 |
| 170 | Parkinsons disease_Homo sapiens_hsa05012 | 0.13787330 |
| 171 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.13591483 |
| 172 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.12185908 |
| 173 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.11038888 |
| 174 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.10708591 |
| 175 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.09328848 |
| 176 | Phagosome_Homo sapiens_hsa04145 | 0.08769389 |

